目的 分析大通合理用药软件(CMDS)在儿科医院的使用情况以及可行性改进方案,为合理用药软件在儿科用药安全领域的研究提供参考。方法 选取2014年6月15日至2014年6月30日经大通合理用药软件审查所示的全院所有问题处方的相关数据,采用Excel软件进行统计和分析。结果 在68 834条提示问题中用法用量问题占了51.2%;涉及用法用量问题的294种药品中有37.1%的药品说明书无儿童剂量信息;74.5%的用法用量问题来自于说明书标注有儿童剂量的药品,且不同剂量计算方式大通合理用药软件的提示均不同程度存在;结合临床实际对提示内容进行具体分析,总体无效警示比例较高。结论 通用型的合理用药软件在儿科使用除了成人医院使用已有问题以外,还存在一些儿科医院特有的问题。基于大数据技术的处方审核系统将是大通等合理用药软件的有效补充。
Abstract
OBJECTIVE To evaluate the effectiveness of using the Clinical Medication Decision Support (CMDS) software in a children′s hospital, discuss the potential improvement METHODS and provide references for researches on rational drug use software applied in pediatric medications.METHODS Problematic prescriptions screened by CMDS from 06/15/2014 to 06/30/2014 were collected. The data were processed and analyzed using microsoft excel. RESULTS Among the 68 834 issues, 51.2% of them were about incorrect dosage and administration. Among the 294 drugs reported by CMDS with issues on dosage and administration, 37.1% had no information for dosage of pediatric use in the drug labels; 74.5% of the issues on dosage and administration corresponded to drugs with complicated pediatric dosage scenarios; while most of these issues had no clinical significance based on further clinical analysis. CONCLUSION Application of rational drug use software for general purpose in children′s hospitals may have specific problems such as difficulty in handling complicated drug dosage scenarios for children. These problems can be solved by leveraging big data technology.
关键词
儿科医院 /
大通合理用药软件 /
合理用药 /
大数据技术 /
处方审核
{{custom_keyword}} /
Key words
children′s hospital /
CMDS /
drug rational use /
big data technology /
prescription screening
{{custom_keyword}} /
中图分类号：
R95
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] HUA X L, ZHAO Y, CHEN C, et al. Application of rational drug monitoring systems in clinical drug usage management and intervention [J]. Chin Hosp Pharm J (中国医院药学杂志), 2013, 33(8):650-652.
[2] SHAO H, LIU N F, CHEN G M, et al. Promoting safety of drug application by PASS and evaluation of PASS [J]. Chin J New Drugs Clin Rem (中国新药与临床杂志), 2008, 27(6):437-441.
[3] WANG Z, ZHANG Z S, JIANG Y. Clinical medication firewall:Yi Yao rational medication management system [J]. Chin Mod Doc (中国现代医生), 2015, 53(19):133-135.
[4] GAO X, LI Z P. The influence of medical staff′s personnel professionality on the pediatric ADR reporting rate in 236 hospitals [J]. Chin Pharm J (中国药学杂志), 2015, 50(2):182-186.
[5] WANG X C, WANG X L, XIE X H, et al. Analysis of information for children in package inserts of medications commonly used in pediatrics of 15 hospitals [J]. Chin Pharm J (中国药学杂志), 2015, 50(16):1446-1450.
[6] WANG A Q, ZHENG X Q. Related thoughts of one case of super drug instructions [J]. Chin Pharm J (中国药学杂志), 2015, 50(8):735-738.
[7] FENG J, JIANG K, ZHU Y R. Analysis of the rationality of clinical drug use with the use of PASS software [J]. Eval Anal Drug-Use Hosp Chin (中国医院用药评价与分析), 2010, 10(8):743-744.
[8] SHI H, ZHANG X L, CHANG M. Evaluation of several rational drug use software in China[J]. Chin Pharm J (中国药学杂志), 2008, 43(13):1033-1035.
[9] LI H X, YU R L, SHU T, et al. Analysis on current status and tendency of rational drug use software in China [J]. Chin Dig Med (中国数字医学), 2011, 6(9):47-50.
[10] WANG X L, GUO C Y. Analysis of present situation of pediatric drug formulations and specifications in foreign countries [J]. Chin Pharm J (中国药学杂志), 2013, 48(17):1316-1320.
[11] CHENG X Q, JIN X L, WANG Y Z, et al. Survey on big data system and analytic technology [J]. J Software (软件学报), 2014, 25(9):1889-1908.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
浙江省教育厅一般科研项目资助(Y201534119);浙江省药学会医院药学专项科研资助项目(2014ZYY06)
{{custom_fund}}
PDF(777 KB)
